07/11 – 09/11 2024

Grand Hyatt/Athens

IASIS PHARMA participated in the “24th PANHELLENIC CONGRESS OF HYPERTENSION” which was held from 07/11 to 09/11 2024, at the Grand Hyatt Hotel/Athens.

The conference was organized by the Hellenic Society of Hypertension (HSH).

IASIS PHARMA presented at its exhibition stand the following products:

  •  RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single dosage form, in packages of 30 f.c. tabs available in the full spectrum of strengths:(Rosuvastatin / Ezetimibe) 5 / 10mg, 10 / 10mg, 20 / 10mg, 40 / 10mg.
  • Rami–Amlo®: Ramipril & Amlodipine, the original fixed dose combination of angiotensin-converting enzyme inhibitors with calcium channel blockers. Therapeutic indication, substitution therapy in patients whose blood pressure is adequately controlled with ramipril and amlodipine simultaneously at the same dose level. (Box of 28 caps, Ramipril / Amlodipine: 5mg / 5mg, 5mg / 10mg, 10mg / 5mg, 10mg / 10mg).
  • Rami–Amlo plus®/ the original fixed dose combination of Ramipril – Amlodipine – Hydrochlorothiazide, indicated for the treatment of Hypertension. (Box of 30 caps, Ramipril / Amlodipine / Hydrochlorothiazide: 5 mg / 5 mg / 12,5 mg, 5 mg / 5 mg / 25 mg, 10 mg / 5 mg / 25 mg, 10 mg / 10 mg / 25 mg).

%cf%85%cf%80%ce%b5%cf%81%cf%84%ce%b1%cf%83%ce%b7-2024-copy